US Broker Ratings

Ionis Pharmaceuticals (IONS) Stock Analysis: Navigating the 10.57% Upside Potential for Biotech Investors

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector with a market cap of $12.03 billion, showcasing its robust presence in the healthcare industry. Based in Carlsbad, California,..

West Pharmaceutical Services (WST) Stock Analysis: A 24.36% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $20.29 billion, West..

Inspire Medical Systems (INSP) Stock Analysis: Unveiling a Potential 62.87% Upside in the Medical Device Market

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneer in the healthcare sector, is making waves with its innovative solutions for obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, the..

ICON plc (ICLR) Investor Outlook: Exploring a 21% Upside with Strong Buy Ratings

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector specializing in diagnostics and research, is a name that might catch your eye, especially given its current market cap of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Riding a 17% Potential Upside Wave

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity. With a market cap of $6.03 billion, this San Francisco-based company is..

Haleon plc (HLN) Stock Analysis: Unpacking the 24.70% Upside Potential and Analyst Ratings

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the investment community with a compelling potential upside of 24.70%, according to current analyst ratings. This..

Elanco Animal Health (ELAN) Stock Analysis: A Look at Growth Potential in the Booming Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a pivotal player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic animal products. With a..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 11.54% Potential Upside and Strong Market Presence Drive Investor Interest

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, particularly in Diagnostics & Research, stands out with a robust market capitalization of $50.36 billion. Headquartered in Westbrook,..

Waters Corporation (WAT) Stock Analysis: Navigating a 1.76% Potential Upside Amid Strong Return on Equity

Waters Corporation (WAT), a prominent player in the healthcare sector, is renowned for its sophisticated analytical workflow solutions. Operating across Asia, the Americas, and Europe, Waters has carved a niche..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Challenging Market with a Resilient Business Model

For investors with an eye on the healthcare sector, Illumina, Inc. (NASDAQ: ILMN) stands out as a key player in the diagnostics and research industry. Renowned for providing cutting-edge sequencing..

Vaxcyte, Inc. (PCVX) Stock Analysis: Eyeing a 116% Upside with Breakthrough Vaccine Innovations

As an investor in the dynamic biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents an intriguing opportunity with its clinical-stage vaccine innovations targeting bacterial infectious diseases. With a current market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Evaluating a 16.82% Potential Upside with Strategic Growth in Healthcare Plans

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, is drawing attention from investors with its projected 16.82% potential upside. The company’s strategic focus on providing..

Johnson & Johnson (JNJ) Stock Analysis: A Solid Healthcare Giant with a 5.66% Upside Potential

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to draw investor interest with its robust market presence and diverse product offerings. With a market capitalization of..

Insulet Corporation (PODD): Investor Outlook Reveals 16% Upside Potential Amid Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector, particularly within the medical devices industry, for its innovative solutions in insulin delivery systems. Headquartered in Acton, Massachusetts, Insulet has..

McKesson Corporation (MCK) Stock Analysis: Evaluating the Growth Potential and Analyst Sentiment

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, continues to command attention with its extensive role in medical distribution. With a market capitalization of $100.92 billion, McKesson stands..

Royalty Pharma plc (RPRX) Stock Analysis: Unlocking 17.46% Potential Upside with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands out in the healthcare sector as a unique entity that specializes in acquiring biopharmaceutical royalties. Founded in 1996 and based in New York, Royalty..

Biogen Inc. (BIIB) Stock Analysis: Leveraging a 13% Potential Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, offers significant opportunities for investors with its focus on developing therapies for neurological and neurodegenerative diseases. With a current..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Strong Buy with 13% Upside Potential in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers promising investment opportunities as per recent analyst ratings. Headquartered..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 32% Potential Upside Amid Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a compelling player in the biotechnology sector, focusing on central nervous system (CNS) disorders. With a market capitalization of $6.74 billion, this New York-based..

Tenet Healthcare Corporation (THC) Investor Outlook: Analyzing the 11.55% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a key player in the healthcare sector, is drawing attention from investors with a notable 11.55% potential upside, according to recent analyst targets. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds